Prescient unveils new platform after 18 months in stealth mode
Australian biotech company Prescient Therapeutics has publicly revealed its high-performing cell therapy enhancement platform named...
Australian biotech company Prescient Therapeutics has publicly revealed its high-performing cell therapy enhancement platform named...
Australian biotechnology company Prescient Therapeutics is enrolling up to 12 new patients for the next...
Cancer-fighting biotech company Prescient Therapeutics has continued to hit its clinical and development milestones in...
A new longitudinal study of cancer patients treated with a revolutionary type of cell therapy...
Biotechnology companies have emerged from the COVID pandemic in “healthy if not robust” shape and...
Prescient Therapeutics’ next-generation CAR-T platform OmniCAR has delivered overwhelmingly positive results in recent pre-clinical studies...
Biotech company Prescient Therapeutics has given investors a glimpse into the progress of it’s next-generation...
Australian biotech company Prescient Therapeutics has achieved numerous milestones in the past financial year as...
Prescient Therapeutics has announced that a global expert in brain cancer, Professor Donald M. O’Rourke,...
CAR-T therapies have proven to be revolutionary treatments for cancer, but their high costs have...
To stay up to date with Prescient Therapeutics news and events, please register your details.